Multiple Myeloma Therapeutics Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2019 – 2028

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Multiple Myeloma Therapeutics Market Year-on-Year Growth, 2020 – 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook, and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Multiple Myeloma Therapeutics Market by Treatment: Market Size and Forecast, 2019 – 2028

4.1    Overview

4.2  Proteasome Inhibitor

4.2.1   Current Trend and Analysis

4.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.3  CD38

4.3.1   Current Trend and Analysis

4.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.4  Immunomodulators

4.4.1   Current Trend and Analysis

4.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.5  Alkylating Agents

4.5.1   Current Trend and Analysis

4.5.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.5.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.6  Others

4.6.1   Current Trend and Analysis

4.6.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.6.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 5        Global Multiple Myeloma Therapeutics Market by Distribution Channel: Market Size and Forecast, 2019 – 2028

5.1  Overview

5.2  Hospital Pharmacy

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.3  Retail Pharmacy

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.4  Drug Store

5.4.1   Current Trend and Analysis

5.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.5  Online Sales

5.5.1   Current Trend and Analysis

5.5.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.5.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 6        Global Multiple Myeloma Therapeutics Market by Geography: Market Size and Forecast, 2019 - 2028

6.1  Overview

6.1.1   Global Multiple Myeloma Therapeutics Market Year-on-Year Growth, by region 2020 – 2028 (%)

6.2  North America

6.2.1   Current Trend and Analysis

6.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3   U.S.

6.2.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3.2        By Treatment

6.2.3.3        By Distribution Channel

6.2.4   Canada

6.2.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.4.2        By Treatment

6.2.4.3        By Distribution Channel

6.2.5   Mexico

6.2.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.5.2        By Treatment

6.2.5.3        By Distribution Channel

6.3    Europe

6.3.1   Current Trend and Analysis

6.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3   UK

6.3.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3.2        By Treatment

6.3.3.3        By Distribution Channel

6.3.4   Russia

6.3.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.4.2        By Treatment

6.3.4.3        By Distribution Channel

6.3.5   France

6.3.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.5.2        By Treatment

6.3.5.3        By Distribution Channel

6.3.6   Italy

6.3.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.6.2        By Treatment

6.3.6.3        By Distribution Channel

6.3.7   Germany

6.3.7.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.7.2        By Treatment

6.3.7.3        By Distribution Channel

6.3.8   Rest of Europe

6.3.8.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.8.2        By Treatment

6.3.8.3        By Distribution Channel

6.4    Asia-Pacific

6.4.1   Current Trend and Analysis

6.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3   China

6.4.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3.2        By Treatment

6.4.3.3        By Distribution Channel

6.4.4   India

6.4.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.4.2        By Treatment

6.4.4.3        By Distribution Channel

6.4.5   Japan

6.4.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.5.2        By Treatment

6.4.5.3        By Distribution Channel

6.4.6   Rest of Asia-Pacific

6.4.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.6.2        By Treatment

6.4.6.3        By Distribution Channel

6.5    RoW

6.5.1   Current Trend and Analysis

6.5.2   Market Size and Forecast

6.5.3   South America

6.5.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.3.2        By Treatment

6.5.3.3        By Distribution Channel

6.5.4   Middle East

6.5.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.4.2        By Treatment

6.5.4.3        By Distribution channel

6.5.5   Africa

6.5.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.5.2        By Treatment

6.5.5.3        By Distribution channel

Chapter 7        Company Profiles

7.1  CELGENE CORPORATION (Bristol Myers Squibb Company).

7.1.1     Company Overview

7.1.2     Product Portfolio

7.1.3     Business Strategies

7.1.4     Financials

7.1.5     Recent Developments

7.2  Takeda Pharmaceutical Company Limited.

7.2.1     Company Overview

7.2.2     Product Portfolio

7.2.3     Business Strategies

7.2.4     Financials

7.2.5     Recent Developments

7.3  Sanofi.

7.3.1     Company Overview

7.3.2     Product Portfolio

7.3.3     Business Strategies

7.3.4     Financials

7.3.5     Recent Developments

7.4  Novartis AG

7.4.1     Company Overview

7.4.2     Product Portfolio

7.4.3     Business Strategies

7.4.4     Financials

7.4.5     Recent Developments

7.5  ONO PHARMACEUTICAL CO., LTD.

7.5.1     Company Overview

7.5.2     Product Portfolio

7.5.3     Business Strategies

7.5.4     Financials

7.5.5     Recent Developments

7.6  AbbVie Inc.

7.6.1     Company Overview

7.6.2     Product Portfolio

7.6.3     Business Strategies

7.6.4     Financials

7.6.5     Recent Developments

7.7  Kayopharm.

7.7.1     Company Overview

7.7.2     Product Portfolio

7.7.3     Business Strategies

7.7.4     Financials

7.7.5     Recent Developments

7.8  Amgen Inc.

7.8.1     Company Overview

7.8.2     Product Portfolio

7.8.3     Business Strategies

7.8.4     Financials

7.8.5     Recent Developments

7.9  Janssen Pharmaceuticals, Inc.

7.9.1     Company Overview

7.9.2     Product Portfolio

7.9.3     Business Strategies

7.9.4     Financials

7.9.5     Recent Developments

7.10   Others.

7.10.1   Company Overview

7.10.2   Product Portfolio

7.10.3   Business Strategies

7.10.4   Financials

7.10.5   Recent Developments

Back to top

Payment Options

Single User $5295
Five User $6195
Enterprise $8199
Datapack $2199
Short Report: $3099